Indefinite Delivery Contract SPE2DR25D1006

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $9,999,999,999. The contract is intended to establish Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency (DHA), Department of Defense (DoD), the U.S. Coast Guard, Designated Providers, Other Government Agencies, and the U.S. Naval Fleet.

The contract encompasses a broad range of pharmaceutical and medical supply products, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. It will have a 30-month base period and three 30-month option periods, for a total estimated value of $30.3 billion. The contract will be awarded on a regional basis, with at least three different contractors selected across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items. Both primary and backup suppliers will provide separate distribution fees for brand/generic and specialty pharmaceuticals to support normal and contingency operations globally.